The Economic Times
English EditionEnglish Editionहिन्दी
| 20 January, 2021, 09:29 AM IST | E-Paper
Search
+

Biocon Ltd.

  • 452.701.10 (0.24%)
  • Volume: 1,92,029
  • Live
  • Last Updated On: 09:29 AM IST
  • Overview
  • News
  • Financials
  • Technicals
  • Peers
  • Shareholdings
  • MF
  • F&O
  • Corporate Actions
  • About

Insights

View All
  • Meeting Agenda: Quarterly Results. Please add to watchlist to track closely.

  • Company has spent 1.02% of its operating revenues towards interest expenses and 22.91% towards employee cost in the year ending Mar 31, 2020. (Source: Consolidated Financials)

  • 50 day moving crossover appeared yesterday. Average price gain of 6.92% within 30 days of this signal in last 5 years.

  • Stock gave a 3 year return of 58.64% as compared to Nifty 100 which gave a return of 27.17%. (as of last trading session)

InsightsBiocon Ltd.

  • Board Meeting on Jan 21, 2021

    Meeting Agenda: Quarterly Results. Please add to watchlist to track closely.

  • Employee & Interest Expense

    Company has spent 1.02% of its operating revenues towards interest expenses and 22.91% towards employee cost in the year ending Mar 31, 2020. (Source: Consolidated Financials)

  • Buy Signal: Bulls on driving seat

    50 day moving crossover appeared yesterday. Average price gain of 6.92% within 30 days of this signal in last 5 years.

  • Stock Returns vs Nifty 100

    Stock gave a 3 year return of 58.64% as compared to Nifty 100 which gave a return of 27.17%. (as of last trading session)

Do you find these insights useful?

  • hate it

  • meh

  • love it

Key Metrics

  • PE Ratio

    PE Ratio

    This is a ratio arrived at by dividing the current market price of a stock by its latest (annual or annualized) earnings per share. Here we have taken the TTM (trailing twelve months) adjusted earnings per share.

    (x)
    83.77
  • EPS - TTM

    EPS - TTM

    Earnings per share (TTM) tells the profit after tax earned on a per share basis by a stock over the last twelve months or four quarters.

    (₹)
    5.37
  • MCap

    MCap

    MCap or Market capitalization of a stock is calculated by multiplying the total number of shares outstanding of that particular stock with its current market price.

    (₹ Cr.)
    54,192.00
  • Sectoral MCap Rank

    Sectoral MCap Rank

    This is the ranking of a company within its sector based on MCap or Market capitalization. Higher the market capitalization of a company, higher the rank it is assigned.

    5
  • PB Ratio

    PB Ratio

    Price to Book represents the ratio of current market price of a stock to its book value per share. The book value itself is arrived at by dividing the net worth of a company by the total number of shares outstanding of the company at that time.

    (x)
    7.34
  • Div Yield

    Dividend Yield

    Dividend Yield calculates the amount of full year dividend declared by a company as a percentage of the current market price of a stock. All other things being equal, higher the dividend yield of the stock, the better it is for investors.

    (%)
    0.07
  • Face Value

    Face Value

    Face value of a stock is the value ascribed to the stock as per the balance sheet of the company. The dividend declared by a company is usually declared as a percentage of face value.

    (₹)
    5.00
  • Beta

    Beta

    1 Month0.87
    3 Months1.37
    6 Months0.95
    1 Year0.98
    3 Years1.08

    0.87
  • VWAP

    VWAP

    Volume Weighted Average Price represents the average price of a security over a particular time period (example one trading day) weighted by the volume traded at each price point.

    (₹)
    451.66
  • 52W H/L

    52W H/L

    This represents the 52 week high and low price of the security. It is also the 1 year high and low of the security. This represents the highest and lowest price touched by the security during the past 52 weeks or 1 year including today.

    (₹)
    487.75 / 235.55

Returns

  • 1 Day-0.31%
  • 1 Week-2.72%
  • 1 Month-4.61%
  • 3 Months2.36%
  • 1 Year54.15%
  • 3 Years58.15%
  • 5 Years460.76%

Financials

  • Income (P&L)
  • Balance Sheet
  • Cash Flow
  • Ratios
  • Insights

    • Employee & Interest Expense

      Company has spent 1.02% of its operating revenues towards interest expenses and 22.91% towards employee cost in the year ending Mar 31, 2020. (Source: Consolidated Financials)
    Quarterly | AnnualSep 2020Jun 2020Mar 2020Dec 2019Sep 2019
    Total Income1,760.301,689.601,644.101,783.901,610.60
    Total Income Growth (%)4.182.77-7.8410.768.09
    Total Expenses1,531.101,424.801,414.801,447.901,233.50
    Total Expenses Growth (%)7.460.71-2.2917.387.02
    EBIT229.20264.80229.30336.00377.10
    EBIT Growth (%)-13.4415.48-31.76-10.9011.77
    PAT169.30149.40123.40202.80215.70
    PAT Growth (%)13.3221.07-39.15-5.984.56
    EBIT Margin (%)13.0215.6713.9518.8423.41
    Net Profit Margin (%)9.628.847.5111.3713.39
    Basic EPS (₹)1.431.261.041.711.82
    Quarterly | AnnualSep 2020Jun 2020Mar 2020Dec 2019Sep 2019
    Total Income598.40556.70549.60552.50584.20
    Total Income Growth (%)7.491.29-0.52-5.4315.43
    Total Expenses498.50429.70440.90394.60458.10
    Total Expenses Growth (%)16.01-2.5411.73-13.8631.11
    EBIT99.90127.00108.70157.90126.10
    EBIT Growth (%)-21.3416.84-31.1625.22-19.53
    PAT95.0084.80102.20120.70106.10
    PAT Growth (%)12.03-17.03-15.3313.76-5.18
    EBIT Margin (%)16.6922.8119.7828.5821.59
    Net Profit Margin (%)15.8815.2318.6021.8518.16
    Basic EPS (₹)0.800.720.861.020.90
    Quarterly | Annual FY 2020 FY 2019 FY 2018 FY 2017 FY 2016
    Total Revenue6,528.605,658.804,329.604,048.203,426.60
    Total Revenue Growth (%)15.3730.706.9518.149.03
    Total Expenses5,381.204,639.403,740.903,214.802,857.60
    Total Expenses Growth (%)15.9924.0216.3612.508.91
    Profit after Tax (PAT)748.20905.30372.40612.10550.40
    PAT Growth (%)-17.35143.10-39.1611.2110.66
    Operating Profit Margin (%)19.0319.7715.7622.0817.87
    Net Profit Margin (%)11.7516.419.0315.7316.44
    Basic EPS (₹)6.327.656.3110.3928.04
    Quarterly | Annual FY 2020 FY 2019 FY 2018 FY 2017 FY 2016
    Total Revenue2,190.103,002.202,543.902,686.702,474.90
    Total Revenue Growth (%)-27.0518.02-5.328.563.52
    Total Expenses1,801.602,648.802,238.102,150.502,026.40
    Total Expenses Growth (%)-31.9818.354.076.124.42
    Profit after Tax (PAT)440.90492.70238.50519.30368.60
    PAT Growth (%)-10.51106.58-54.0740.882.05
    Operating Profit Margin (%)19.5912.3412.6820.8619.56
    Net Profit Margin (%)22.1717.079.8520.0616.01
    Basic EPS (₹)3.688.334.0426.4518.78

    All figures in Rs Cr, unless mentioned otherwise

  • Annual FY 2020 FY 2019 FY 2018 FY 2017 FY 2016
    Total Assets14,443.8012,192.409,989.709,394.208,458.10
    Total Assets Growth (%)18.4722.056.3411.0732.67
    Total Liabilities7,060.705,485.504,341.204,180.404,158.50
    Total Liabilities Growth (%)28.7226.363.850.5341.80
    Total Equity7,383.106,706.905,648.505,213.804,299.60
    Total Equity Growth (%)10.0818.748.3421.2624.89
    Current Ratio (x)1.331.611.942.412.38
    Total Debt to Equity (x)0.280.290.370.460.61
    Contingent Liabilities1,489.901,600.601,115.90786.50803.60
    Annual FY 2020 FY 2019 FY 2018 FY 2017 FY 2016
    Total Assets8,310.808,240.407,726.907,468.907,098.10
    Total Assets Growth (%)0.856.653.455.22112.96
    Total Liabilities773.501,125.00988.30927.801,101.50
    Total Liabilities Growth (%)-31.2413.836.52-15.7747.14
    Total Equity7,537.307,115.406,738.606,541.105,996.60
    Total Equity Growth (%)5.935.593.029.08132.03
    Current Ratio (x)2.862.462.473.372.75
    Total Debt to Equity (x)0.000.000.010.020.06
    Contingent Liabilities2,203.701,932.801,797.701,708.601,644.30

    All figures in Rs Cr, unless mentioned otherwise

  • Insights

    • Increase in Cash from Investing

      Company has used Rs 1558.9 cr for investing activities which is an YoY increase of 118.39%. (Source: Consolidated Financials)
    Annual FY 2020 FY 2019 FY 2018 FY 2017 FY 2016
    Net Cash flow from Operating Activities1,283.101,154.60662.10640.00370.60
    Net Cash used in Investing Activities-1,558.90-713.80-684.00-498.50-1,141.70
    Net Cash flow from Financing Activities387.60-241.70-239.70-177.501,067.60
    Net Cash Flow165.40210.30-261.20-47.30300.00
    Closing Cash & Cash Equivalent824.70659.30449.00710.20757.50
    Closing Cash & Cash Equivalent Growth (%)25.0946.84-36.78-6.2463.75
    Total Debt/ CFO (x)1.471.552.903.456.66
    Annual FY 2020 FY 2019 FY 2018 FY 2017 FY 2016
    Net Cash flow from Operating Activities387.10109.50355.20185.80208.50
    Net Cash used in Investing Activities-212.90310.90-555.50110.40-321.10
    Net Cash flow from Financing Activities-128.90-208.20-54.60-238.3073.00
    Net Cash Flow69.30216.60-252.5051.50-31.80
    Closing Cash & Cash Equivalent375.00305.7089.10341.60290.10
    Closing Cash & Cash Equivalent Growth (%)22.67243.10-73.9217.75-8.17
    Total Debt/ CFO (x)0.000.010.190.711.74

    All figures in Rs Cr, unless mentioned otherwise

  • Annual FY 2020 FY 2019 FY 2018 FY 2017 FY 2016
    Return on Equity (%)11.1514.847.1812.6513.64
    Return on Capital Employed (%)11.6111.918.2811.138.80
    Return on Assets (%)5.187.423.726.516.50
    Interest Coverage Ratio (x)18.6815.3810.5733.0520.42
    Asset Turnover Ratio (x)44.0845.2241.2741.4239.57
    Price to Earnings (x)43.4840.6596.1537.0417.54
    Price to Book (x)4.846.016.884.692.39
    EV/EBITDA (x)19.2924.7035.4721.3012.79
    EBITDA Margin (%)27.7127.8925.1029.2125.30
    Annual FY 2020 FY 2019 FY 2018 FY 2017 FY 2016
    Return on Equity (%)5.856.923.537.946.14
    Return on Capital Employed (%)5.134.914.447.987.22
    Return on Assets (%)5.305.973.086.955.19
    Interest Coverage Ratio (x)324.75136.92306.80142.11237.05
    Asset Turnover Ratio (x)23.9235.0031.3034.6432.42
    Price to Earnings (x)74.0774.63151.5243.6726.18
    Price to Book (x)4.315.155.293.471.61
    EV/EBITDA (x)65.8172.1680.2032.4615.86
    EBITDA Margin (%)24.5217.4418.3026.6825.63

Financial InsightsBiocon Ltd.

  • Income (P&L)
  • Cash Flow
    • Employee & Interest Expense

      Company has spent 1.02% of its operating revenues towards interest expenses and 22.91% towards employee cost in the year ending Mar 31, 2020. (Source: Consolidated Financials)

    • Increase in Cash from Investing

      Company has used Rs 1558.9 cr for investing activities which is an YoY increase of 118.39%. (Source: Consolidated Financials)

Do you find these insights useful?

  • hate it

  • meh

  • love it

Technicals

  • Buy / Sell Signals
  • Price Analysis
  • Pivot Levels & ATR
  • Chart
  • Bullish / Bearish signals for Biocon Ltd. basis selected technical indicators and moving average crossovers.

    50 Day EMA Crossover

    Bullish signal on daily chart

    Appeared on: 19 Jan 2021

    50D EMA: 451.11

    Last 4 Buy Signals:26 Nov 2020
    Date30 days Gain/Loss %
    26 Nov 202014.56%
    24 Nov 20202.41%
    12 Nov 20203.70%
    25 Sep 202011.68%

    Average price gain of 6.92% within 30 days of Bullish signal in last 5 years

    MACD Crossover

    Bearish signal on weekly chart

    Appeared on: 15 Jan 2021

    Region: Positive

    Last 4 Sell Signals:23 Oct 2020
    Date7 weeks Gain/Loss %
    23 Oct 2020-6.58%
    14 Aug 2020-5.78%
    20 Mar 2020-8.93%
    15 Feb 2019-1.83%

    Average price decline of -5.29% within 7 weeks of Bearish signal in last 10 years

    5 Day EMA Crossover

    Bearish signal on daily chart

    Appeared on: 15 Jan 2021

    5D EMA: 463.10

    Last 4 Sell Signals:13 Jan 2021
    Date7 days Gain/Loss %
    13 Jan 2021-0.92%
    6 Jan 2021-1.28%
    28 Dec 2020-2.69%
    21 Dec 2020-2.89%

    Average price decline of -2.63% within 7 days of Bearish signal in last 5 years

    Show More
  • 43%
    Positive Movement since
    1st Jan 2005 on basis
    56%
    Negative Movement since
    1st Jan 2005 on basis
    Exclude
  • Pivot Levels

    R1R2R3PIVOTS1S2S3
    Classic455.72459.83467.13452.53448.42445.23437.93

    Average True Range

    5 DAYS14 DAYS28 DAYS
    ATR12.0412.7513.15

Peer Comparison

  • Stock Performance
  • Ratio Performance
  • Insights

    • Stock Returns vs Nifty 100

      Stock gave a 3 year return of 58.64% as compared to Nifty 100 which gave a return of 27.17%. (as of last trading session)
    • Stock Returns vs Nifty Pharma

      Stock generated 58.64% return as compared to Nifty Pharma which gave investors 31.29% return over 3 year time period. (as of last trading session)
    • 1D
    • 1W
    • 1M
    • 3M
    • 6M
    • 1Y
    • 5Y
  • Insights

    • Stock Returns vs Nifty 100

      Stock gave a 3 year return of 58.64% as compared to Nifty 100 which gave a return of 27.17%. (as of last trading session)
    • Stock Returns vs Nifty Pharma

      Stock generated 58.64% return as compared to Nifty Pharma which gave investors 31.29% return over 3 year time period. (as of last trading session)

    Ratio Performance

    NAMEP/E (x)P/B (x)ROE %ROCE %ROA %Rev CAGR [3Yr]OPMNPMBasic EPSCurrent RatioTotal Debt/ Equity (x)Total Debt/ CFO (x)
    Biocon84.037.3411.1511.615.1817.0819.0314.136.321.330.281.47
    Dr. Reddys52.595.4312.9812.048.727.9911.0011.24122.221.750.110.60
    Cipla36.044.139.8112.326.536.0613.869.0219.192.660.180.92
    Aurobindo Pharm17.243.2216.8423.319.7815.5617.7012.3148.321.440.321.24
    Cadila Health29.384.2411.3314.274.9614.6115.448.2411.491.050.682.81
    Add More
    Annual Ratios (%)

    Choose from Peers

    • Lupin
    • Torrent Pharma
    • Gland Pharma
    • Alkem Lab
    • Ipca Labs

    Choose from Stocks

    Peers InsightsBiocon Ltd.

    • Stock Returns vs Nifty 100

      Stock gave a 3 year return of 58.64% as compared to Nifty 100 which gave a return of 27.17%. (as of last trading session)

    • Stock Returns vs Nifty Pharma

      Stock generated 58.64% return as compared to Nifty Pharma which gave investors 31.29% return over 3 year time period. (as of last trading session)

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Shareholding Pattern

    • QOQ Change
    • Total Shareholdings
    • Showing Shareholding as on 31 Dec 2020
      Category31 Dec 202030 Sep 202030 Jun 202031 Mar 2020
      Promoters60.6760.6760.6760.67
      Pledge0.000.000.000.00
      FII18.3317.3616.6515.54
      DII5.355.636.476.76
      Mutual Funds3.053.944.695.13
      Others15.6516.3416.2117.03
    • Showing Shareholding as on 31 Dec 2020
      CategoryNo. of SharesPercentage% Change QoQ
      Promoters72,80,24,17660.67 %0.00
      Pledge00.00 %0.00
      FII21,99,80,11718.33 %0.97
      DII6,42,38,3325.35 %-0.28
      MF3,66,52,4703.05 %-0.89
      Others18,77,57,37515.65 %-0.69

    MF Ownership

    MF Ownership as on 31 December 2020

    F&O Quote

    • Futures
    • Options
      • Expiry

      Price

      453.153.85 (0.86%)

      OpenHighLowPrev CloseContracts TradedTurnover (₹ Lakhs)
      452.00456.85450.20449.301,45915,226.24

    Corporate Actions

    • Board Meeting/AGM
    • Dividends
    • Others
    • Meeting DateAnnounced onPurposeDetails
      Jan 21, 2021Jan 05, 2021Board MeetingQuarterly Results
      Oct 22, 2020Oct 06, 2020Board MeetingQuarterly Results
      Jul 24, 2020Jul 01, 2020AGM-
      Jul 23, 2020Jul 07, 2020Board MeetingQuarterly Results
      Jul 23, 2020Jul 01, 2020AGM-
    • TypeDividendDividend per ShareEx-Dividend DateAnnounced on
      Final10%0.5Jul 18, 2019Apr 25, 2019
      Final20%1.0Jul 19, 2018Apr 26, 2018
      Final20%1.0Jul 20, 2017May 02, 2017
      Interim100%5.0Mar 17, 2016Mar 08, 2016
      Interim100%5.0Apr 09, 2015Mar 27, 2015
    • All TypesEx-DateRecord DateAnnounced onDetails
      BonusJun 12, 2019Jun 13, 2019Apr 25, 2019Bonus Ratio: 1 share(s) for every 1 shares held
      BonusJun 15, 2017Jun 17, 2017Apr 27, 2017Bonus Ratio: 2 share(s) for every 1 shares held
      BonusSep 11, 2008Sep 12, 2008Apr 22, 2008Bonus Ratio: 1 share(s) for every 1 shares held

    About Biocon

    Biocon Ltd., incorporated in the year 1978, is a Large Cap company (having a market cap of Rs 54192.00 Crore) operating in Pharmaceuticals sector. Biocon Ltd. key Products/Revenue Segments include Bio Pharmaceuticals which contributed Rs 1811.70 Crore to Sales Value (91.11 % of Total Sales), Other Operating Revenue which contributed Rs 157.50 Crore to Sales Value (7.92 % of Total Sales), Waste which contributed Rs 15.80 Crore to Sales Value (0.79 % of Total Sales) and Sale of services which contributed Rs 3.40 Crore to Sales Value (0.17 % of Total Sales)for the year ending 31-Mar-2020. Show More

    • Executives
    • Auditors
    • AV

      A V Sriram

      Head
      AS

      Amitava Saha

      Head - Human Resource
      BS

      B S V Prasad

      Chief Operating Officer
      BK

      Bobby Kanubhai Parikh

      Independent Director
      Show More
    • B S R & Co. LLP

    Key Indices Listed on

    Nifty Next 50, Nifty 100, Nifty 200, + 25 more

    Address

    20th K.M. Hosur Road,Electronics City,Bengaluru, Karnataka - 560100

    Biocon Share Price Update

    Biocon Ltd. share price moved up by 0.24% from its previous close of Rs 451.60. Biocon Ltd. stock last traded price is 452.70

    Share PriceValue
    Today/Current/Last452.70
    Previous Day451.60

    Trending in Markets

    DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

    DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

    By using this site, you agree to the Terms of Service and Privacy Policy.

    The Economic Times